Literature DB >> 35666962

Medicaid Managed Care: Access To Primary Care Providers Who Prescribe Buprenorphine.

Mark Katz Meiselbach1, Coleman Drake2, Brendan Saloner3, Jane M Zhu4, Bradley D Stein5, Daniel Polsky6.   

Abstract

Medicaid managed care insurers play a crucial role in facilitating access to buprenorphine to treat opioid use disorder. Using a novel set of provider directory and prescription claims data, we examined variation in access to in-network buprenorphine-prescribing primary care providers among Medicaid managed care enrollees. Approximately 32.2 percent of enrollees had fewer than one in-network buprenorphine prescriber per 100,000 county residents. On average, there were a greater number of in-network buprenorphine-prescribing primary care providers in states with higher compared with lower overdose death rates. However, most enrollees lived in areas with a shortage of these providers. We found that a 25 percent higher network participation rate by prescribers compared with nonprescribers could improve the probability that enrollees see a prescriber by approximately 25 percent. Policies to improve access within Medicaid managed care include using primary care provider assignment algorithms to match patients with buprenorphine prescribers and requiring that networks include a minimum number of buprenorphine prescribers.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35666962      PMCID: PMC9245197          DOI: 10.1377/hlthaff.2021.01719

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   9.048


  27 in total

1.  Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Michael I Fingerhood; Brendan Saloner
Journal:  Drug Alcohol Depend       Date:  2017-07-11       Impact factor: 4.492

2.  The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.

Authors:  Evan S Cole; Ellen DiDomenico; Gerald Cochran; Adam J Gordon; Walid F Gellad; Janice Pringle; Jack Warwick; Chung-Chou H Chang; Joo Yeon Kim; Julie Kmiec; David Kelley; Julie M Donohue
Journal:  J Gen Intern Med       Date:  2019-03-18       Impact factor: 5.128

3.  Policies to Improve Substance Use Disorder Treatment With Telehealth During the COVID-19 Pandemic and Beyond.

Authors:  Coleman Drake; Jiani Yu; Nicole Lurie; Kevin Kraemer; Daniel Polsky; Krisda H Chaiyachati
Journal:  J Addict Med       Date:  2020 Sep/Oct       Impact factor: 3.702

4.  Retention in buprenorphine treatment is associated with improved HCV care outcomes.

Authors:  B L Norton; A Beitin; M Glenn; J DeLuca; A H Litwin; C O Cunningham
Journal:  J Subst Abuse Treat       Date:  2017-01-27

Review 5.  Chronic illness management: what is the role of primary care?.

Authors:  Arlyss Anderson Rothman; Edward H Wagner
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

6.  Supply of buprenorphine waivered physicians: the influence of state policies.

Authors:  Bradley D Stein; Adam J Gordon; Andrew W Dick; Rachel M Burns; Rosalie Liccardo Pacula; Carrie M Farmer; Douglas L Leslie; Mark Sorbero
Journal:  J Subst Abuse Treat       Date:  2014-08-02

7.  Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners.

Authors:  Sandra A Springer; Jingjun Qiu; Ali Shabahang Saber-Tehrani; Frederick L Altice
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

8.  Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others.

Authors:  Mark Olfson; Victoria Zhang; Michael Schoenbaum; Marissa King
Journal:  Health Aff (Millwood)       Date:  2020-06       Impact factor: 9.048

9.  Breadth and Exclusivity of Hospital and Physician Networks in US Insurance Markets.

Authors:  John A Graves; Leonce Nshuti; Jordan Everson; Michael Richards; Melinda Buntin; Sayeh Nikpay; Zilu Zhou; Daniel Polsky
Journal:  JAMA Netw Open       Date:  2020-12-01

10.  A comparison of methods for measuring spatial access to health care.

Authors:  Coleman Drake; Dylan Nagy; Thuy Nguyen; Kevin L Kraemer; Christina Mair; David Wallace; Julie Donohue
Journal:  Health Serv Res       Date:  2021-07-11       Impact factor: 3.734

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.